Plasma miR-134-5p: a candidate biomarker for predicting non-response to anti-TNF therapy in rheumatoid arthritis.

Front Immunol · 2026 · PMC13036163 · PMID 41924283

Europe PMC DOI

hedged sentence

0.1500

closest p · 3.0× alpha

0.1500

boldest claim

The sentences

showed a trendp < 0.15not close (p > 0.1)

Models comparing responders vs non-responders were adjusted for age, sex, smoking status, baseline DAS28-CRP, and baseline glucocorticoid use; smoking status showed a trend toward association in these models (p < 0.15) but did not reach conventional statistical significance (p ≥ 0.05).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.